000 02391 a2200721 4500
005 20250513222453.0
264 0 _c20010105
008 200101s 0 0 eng d
022 _a1074-5521
024 7 _a10.1016/s1074-5521(00)00025-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCoghlan, M P
245 0 0 _aSelective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
_h[electronic resource]
260 _bChemistry & biology
_cOct 2000
300 _a793-803 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenosine Triphosphate
_xantagonists & inhibitors
650 0 4 _aAminophenols
_xpharmacology
650 0 4 _aBinding, Competitive
650 0 4 _aCalcium-Calmodulin-Dependent Protein Kinases
_xantagonists & inhibitors
650 0 4 _aCell Line
650 0 4 _aCytoskeletal Proteins
_xgenetics
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aGenes, Reporter
650 0 4 _aGlycogen
_xbiosynthesis
650 0 4 _aGlycogen Synthase
_xmetabolism
650 0 4 _aGlycogen Synthase Kinase 3
650 0 4 _aGlycogen Synthase Kinases
650 0 4 _aHumans
650 0 4 _aIndoles
_xpharmacology
650 0 4 _aKinetics
650 0 4 _aLiver
_xcytology
650 0 4 _aMaleimides
_xpharmacology
650 0 4 _aMolecular Structure
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aProtein Kinases
_xmetabolism
650 0 4 _aRecombinant Proteins
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTrans-Activators
650 0 4 _aTranscription, Genetic
_xdrug effects
650 0 4 _abeta Catenin
700 1 _aCulbert, A A
700 1 _aCross, D A
700 1 _aCorcoran, S L
700 1 _aYates, J W
700 1 _aPearce, N J
700 1 _aRausch, O L
700 1 _aMurphy, G J
700 1 _aCarter, P S
700 1 _aRoxbee Cox, L
700 1 _aMills, D
700 1 _aBrown, M J
700 1 _aHaigh, D
700 1 _aWard, R W
700 1 _aSmith, D G
700 1 _aMurray, K J
700 1 _aReith, A D
700 1 _aHolder, J C
773 0 _tChemistry & biology
_gvol. 7
_gno. 10
_gp. 793-803
856 4 0 _uhttps://doi.org/10.1016/s1074-5521(00)00025-9
_zAvailable from publisher's website
999 _c10978177
_d10978177